Jane Street Group, LLC Graphite Bio, Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.24 - $2.66 $72,107 - $85,628	32,191 New	32,191 $84,000
Q1 2023 May 15, 2023	BUY	$1.85 - $3.21 $102,998 - $178,716	55,675 New	55,675 $136,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $32,548 - $48,938	11,542 New	11,542 $37,000
Q3 2022 Nov 14, 2022	BUY	$2.82 - $4.24 $32,548 - $48,938	11,542 New	11,542 $37,000
Q1 2022 May 17, 2022	SELL	$5.1 - $13.06 $213,485 - $546,691	-41,860 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$8.41 - $16.71 $352,042 - $699,480	41,860 New	41,860 $520,000
Q3 2021 Nov 16, 2021	SELL	$15.81 - $28.39 $240,707 - $432,237	-15,225 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.5 - $30.73 $281,662 - $467,864	15,225 New	15,225 $468,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.